Overcoming time pressure and the global shortage of test kits and reagents, the 8-member Microbiology team from Gleneagles Hospital Hong Kong’s Clinical Laboratory has made in-house COVID-19 testing a reality, about two months after Hong Kong confirmed its first COVID-19 case.
Today, Gleneagles Hospital Hong Kong is capable of testing up to 150 COVID-19 samples daily in its laboratory. It uses two test platforms (POCT or point of care testing and PCR or polymerase chain reaction testing), to provide quality and efficient service to meet our patients’ needs.
Between end of March and end of May, the hospital tested more than 200 cases, while supporting the Hong Kong Government Department of Health’s Community Deep Throat Saliva Surveillance Programme with about 300 cases.
The team is ramping up the laboratory’s testing capacity to meet the anticipated surge in testing demand as the government prepares to open up its borders to businesses travellers with negative COVID-19 nucleic acid testing result certification.
By making COVID-19 testing available to our patients and the medical needs of our clinicians, Gleneagles Hospital Hong Kong is helping to stem the spread of the virus in the community. It is also keeping our hospital safe for our inpatients and frontline staff, ensuring that it continues to provide uninterrupted healthcare services during the COVID-19 pandemic.
Related Stories
Transformation Takes Centerstage at the Parkway Laboratories Staff Town Hall
Transformation was the heartbeat of the day at Parkway Laboratories' 2025 staff town hall on 11 April 2025.
Pantai Hospital Penang Marks 7 Years of Family Rewards Club
On 29 March 2025, Pantai Hospital Penang celebrated the 7th anniversary of its Family Rewards Club with an exhilarating 7km Pantai Fun Run.
-(9).png?sfvrsn=3a9bdc39_1)
IHH Malaysia Shares Ramadan Blessings with Local Communities
Throughout Ramadan, many of our hospitals in Malaysia reached out to underserved communities with meaningful acts of compassion—reflecting IHH Malaysia’s commitment to giving back and fostering stronger social bonds.
Fortis Hospital Shalimar Bagh Champions Gender Equality with Walkathon
Advancing Treatment for Pulmonary Arterial Hypertension: An Approach with Sotatercept
A development in Pulmonary Arterial Hypertension (PAH) treatment took place at Mount Elizabeth Hospital, Singapore, where a patient received Sotatercept — a therapy that offers additional possibilities for managing this complex condition. This reflects ongoing progress in cardiology and pulmonary hypertension care.
